BY ALBERT RONNING-ANDERSSON
-
Novo Holdings founds new biotech company with USD 15m in backing
The brand-new firm will at first concentrate on neuro-degenerative illness such as Parkinson’s and Alzheimer’s.
-
Danish biotech firm to start US trials of obesity drug
The company has actually been given FDA clearance to begin a Stage I test in the United States, analyzing the security, tolerability and pharmacokinetics of the weight problems pro…
-
WS Audiology expands executive board to include US regional head
Carsten Buhl, that has actually been head of the hearing team WS Audiology in the Americas area because 2022, is signing up with the Exec Board with prompt result.
-
Galecto acquires new cancer asset in exchange for company shares
At the very same time, the Danish biotech business racks a cancer cells prospect in stage II.
-
Eli Lilly invests USD 4.5bn in new research and manufacturing facility
The billion-dollar structure is anticipated to open up in 2027 and will certainly use 400 individuals.
-
Five out of six Coloplast executives have sold shares within two weeks
In Between 30 August and 16 September, 5 out of 6 participants of Coloplast’s elderly monitoring group marketed shares for an overall gain of greater than USD 2 million.
-
New survey: Danes are not using obesity drug as intended
Remarkably couple of get to the high advised dosage of Wegovy however continue to be at the reduced dosages, according to a study of weight problems substance abuse in Denmark.
-
Novo Holdings bets big on US pharma company: Invests USD 50 million in extension equity financing
US-based Path 92 Medical will certainly utilize the cash to speed up worldwide commercialization of its items and to seek governing authorizations in brand-new locations.
-
Coloplast chairman has sold 94% of his shares to pursue “new business opportunity”
Coloplast Chairman Lars Rasmussen has actually been provided the chance to buy a business outside the life scientific research market. He desires maintain his placement as Chairman…
-
Novo Holdings bets big on US pharma company: Invests USD 50 million in extension equity financing
US-based Route 92 Medical will use the money to accelerate global commercialization of its products and to pursue regulatory approvals in new geographies.
